Ron Squarer
CIK 1454001 · CEO · last filed 2026-06-03
Ron Squarer is a CEO who has filed 52 SEC Form 4 insider transactions across 6 companies since 2009. The most recent filing, for ADCT, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.54M
6
52
-$1.72M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | Director | 138,627 | $1.05 | $145.6K | -$20.2K | 5 | 2026-06-03 |
| TVTX | Director | 39,375 | $52.04 | $2.05M | $0 | 6 | 2026-05-21 |
| NUVL | Director | 2,837 | $123.25 | $349.7K | $0 | 1 | 2025-12-11 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Director | — | $25.59 | — | $0 | 12 | 2024-06-11 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 11,875 | — | — | $0 | 4 | 2020-05-19 |
| HOSPIRA INC (HSP) Delisted | Chief Commercial Officer | 19,563 | — | — | -$1.70M | 6 | 2011-02-28 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | ADCT | Mixed | +29,804 | -$46.8K | EDGAR |
| 2026-05-21 | TVTX | Grant (A) | +4,000 | $0 | EDGAR |
| 2025-12-11 | NUVL | Grant (A) | +2,837 | $0 | EDGAR |
| 2025-06-17 | ADCT | Tax (F) | −15,184 | -$54.4K | EDGAR |
| 2025-06-05 | ADCT | Grant (A) | +40,000 | $0 | EDGAR |
| 2025-05-16 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |
| 2024-06-18 | ADCT | Sell (S) | −6,995 | -$20.2K | EDGAR |
| 2024-06-14 | ADCT | Grant (A) | +40,000 | $0 | EDGAR |
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-05-10 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |